MOTCO’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$579K Buy
12,075
+1,557
+15% +$66.9K 0.05% 135
2026
Q1
$387K Sell
10,518
-1,050
-9% -$49.8K 0.04% 156
2025
Q4
$589K Sell
11,568
-511
-4% -$26.1K 0.05% 145
2025
Q3
$670K Buy
12,079
+1,414
+13% +$82.8K 0.06% 138
2025
Q2
$502K Buy
10,665
+1,005
+10% +$68.4K 0.05% 146
2025
Q1
$671K Buy
9,660
+819
+9% +$67.6K 0.07% 130
2024
Q4
$761K Sell
8,841
-320
-3% -$34.6K 0.08% 130
2024
Q3
$1.09M Buy
9,161
+91
+1% +$12.1K 0.11% 118
2024
Q2
$1.29M Sell
9,070
-1,351
-13% -$179K 0.08% 148
2024
Q1
$1.34M Sell
10,421
-899
-8% -$107K 0.08% 151
2023
Q4
$1.17M Buy
11,320
+7,486
+195% +$740K 0.08% 149
2023
Q3
$349K Buy
3,834
+3,306
+626% +$291K 0.02% 190
2023
Q2
$42.7K Buy
+528
New +$43.1K ﹤0.01% 368
2019
Q1
Sell
-2
Closed 549
2018
Q4
$0 Buy
+2
New +$44 ﹤0.01% 587
2016
Q4
Sell
-218
Closed -$5K 622
2016
Q3
$5K Buy
+218
New +$5.41K ﹤0.01% 532
2015
Q3
Sell
-500
Closed -$14K 609
2015
Q2
$14K Hold
500
﹤0.01% 405
2015
Q1
$13K Hold
500
﹤0.01% 406
2014
Q4
$11K Hold
500
﹤0.01% 455
2014
Q3
$12K Hold
500
﹤0.01% 441
2014
Q2
$12K Hold
500
﹤0.01% 436
2014
Q1
$11K Hold
500
﹤0.01% 428
2013
Q4
$9K Hold
500
﹤0.01% 481
2013
Q3
$8K Hold
500
﹤0.01% 474
2013
Q2
$8K Buy
+500
New +$8.32K ﹤0.01% 489

Other funds holding NVO

MOTCO's NVO Position: Q2 2026 in Review

MOTCO increased its Novo Nordisk (NVO) stake by 15% in Q2 2026, buying an estimated $66.9K and bringing the position to 12,075 shares worth $579K. The position accounts for 0.05% of the portfolio, ranked #135.

MOTCO first reported a position in NVO in Q2 2013 and has held it in 24 quarters since. The position peaked at $1.34M in Q1 2024. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • MOTCO held 12,075 shares of Novo Nordisk worth $579K as of Q2 2026.
  • MOTCO bought 1,557 Novo Nordisk shares in Q2 2026, an estimated $66.9K.
  • Novo Nordisk made up 0.05% of MOTCO's portfolio in Q2 2026, its #135 holding.
  • MOTCO first reported a position in Novo Nordisk in Q2 2013 and has held it in 24 quarters since.
  • MOTCO's Novo Nordisk position peaked at $1.34M in Q1 2024.
  • 1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on MOTCO's 13F filing for Q2 2026, filed 31 Jul 2026.